Kanawha Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
8,767
+124
| +1% | +$15.7K | 0.08% | 112 |
|
|
2025
Q1 | $1.11M | Sell |
8,643
-296
| -3% | -$37.9K | 0.09% | 111 |
|
|
2024
Q4 | $1.18M | Buy |
8,939
+555
| +7% | +$73.4K | 0.09% | 108 |
|
|
2024
Q3 | $1.22M | Buy |
8,384
+1,432
| +21% | +$208K | 0.09% | 116 |
|
|
2024
Q2 | $954K | Buy |
6,952
+2,705
| +64% | +$371K | 0.07% | 126 |
|
|
2024
Q1 | $583K | Buy |
4,247
+970
| +30% | +$133K | 0.05% | 152 |
|
|
2023
Q4 | $445K | Buy |
3,277
+375
| +13% | +$50.9K | 0.04% | 157 |
|
|
2023
Q3 | $355K | Sell |
2,902
-40
| -1% | -$4.89K | 0.03% | 164 |
|
|
2023
Q2 | $374K | Buy |
2,942
+40
| +1% | +$5.08K | 0.03% | 160 |
|
|
2023
Q1 | $375K | Buy |
2,902
+140
| +5% | +$18.1K | 0.04% | 162 |
|
|
2022
Q4 | $363K | Sell |
2,762
-25
| -0.9% | -$3.29K | 0.04% | 164 |
|
|
2022
Q3 | $326K | Buy |
2,787
+45
| +2% | +$5.26K | 0.04% | 158 |
|
|
2022
Q2 | $323K | Buy |
2,742
+5
| +0.2% | +$589 | 0.03% | 162 |
|
|
2022
Q1 | $357K | Buy |
2,737
+57
| +2% | +$7.44K | 0.03% | 167 |
|
|
2021
Q4 | $409K | Hold |
2,680
| – | – | 0.03% | 159 |
|
|
2021
Q3 | $433K | Hold |
2,680
| – | – | 0.04% | 152 |
|
|
2021
Q2 | $439K | Buy |
2,680
+25
| +0.9% | +$4.1K | 0.04% | 157 |
|
|
2021
Q1 | $400K | Hold |
2,655
| – | – | 0.04% | 156 |
|
|
2020
Q4 | $402K | Hold |
2,655
| – | – | 0.04% | 154 |
|
|
2020
Q3 | $360K | Hold |
2,655
| – | – | 0.04% | 155 |
|
|
2020
Q2 | $363K | Sell |
2,655
-171
| -6% | -$23.4K | 0.04% | 151 |
|
|
2020
Q1 | $304K | Hold |
2,826
| – | – | 0.04% | 151 |
|
|
2019
Q4 | $341K | Buy |
+2,826
| New | +$341K | 0.04% | 157 |
|